NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
LEO Pharma A/S, a global leader in medical dermatology, today announced it will present 23 scientific posters at Maui Derm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results